title: Somatostatin for the treatment of upper gastrointestinal bleeding (UGIB) in patients undergoing autologous bone marrow transplantation (ABMT)
authors.forename: A
authors.initials: A
authors.lastname: Sambresqui
authors.forename: M
authors.initials: M
authors.lastname: Zylberman
authors.forename: C
authors.initials: C
authors.lastname: Foncuberta
authors.forename: D
authors.initials: D
authors.lastname: Ceraso
authors.forename: E
authors.initials: E
authors.lastname: Torello
authors.forename: R
authors.initials: R
authors.lastname: Bayo
authors.forename: B
authors.initials: B
authors.lastname: Koziner
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy*; D006801:Humans; D012189:Retrospective Studies; D013004:Somatostatin / Q000627:therapeutic use*; D014182:Transplantation, Autologous
chemical_list: D013004:Somatostatin